274 related articles for article (PubMed ID: 34081971)
21. Bone mass density following developmental exposures to perfluoroalkyl substances (PFAS): a longitudinal cohort study.
Blomberg A; Mortensen J; Weihe P; Grandjean P
Environ Health; 2022 Nov; 21(1):113. PubMed ID: 36402982
[TBL] [Abstract][Full Text] [Related]
22. Early-life exposure to perfluoroalkyl substances in relation to serum adipokines in a longitudinal birth cohort.
Shih YH; Blomberg AJ; Jørgensen LH; Weihe P; Grandjean P
Environ Res; 2022 Mar; 204(Pt A):111905. PubMed ID: 34419464
[TBL] [Abstract][Full Text] [Related]
23. Maternal exposure to perfluoroalkyl chemicals and anogenital distance in the offspring: A Faroese cohort study.
Christensen JVR; Bangash KK; Weihe P; Grandjean P; Nielsen F; Jensen TK; Petersen MS
Reprod Toxicol; 2021 Sep; 104():52-57. PubMed ID: 34182087
[TBL] [Abstract][Full Text] [Related]
24. Serum per- and polyfluoroalkyl substances and abnormal lipid metabolism: A nationally representative cross-sectional study.
Wu B; Pan Y; Li Z; Wang J; Ji S; Zhao F; Chang X; Qu Y; Zhu Y; Xie L; Li Y; Zhang Z; Song H; Hu X; Qiu Y; Zheng X; Zhang W; Yang Y; Gu H; Li F; Cai J; Zhu Y; Cao Z; S Ji J; Lv Y; Dai J; Shi X
Environ Int; 2023 Feb; 172():107779. PubMed ID: 36746113
[TBL] [Abstract][Full Text] [Related]
25. Associations between perfluoroalkyl substances and lipid profile in a highly exposed young adult population in the Veneto Region.
Canova C; Barbieri G; Zare Jeddi M; Gion M; Fabricio A; Daprà F; Russo F; Fletcher T; Pitter G
Environ Int; 2020 Dec; 145():106117. PubMed ID: 32971418
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein profiles associated with exposure to poly- and perfluoroalkyl substances (PFASs) in the EuroMix human biomonitoring study.
Papadopoulou E; Nicolescu A; Haug LS; Husøy T; Deleanu C; Dirven H; Lindeman B
Environ Pollut; 2022 Sep; 308():119664. PubMed ID: 35738521
[TBL] [Abstract][Full Text] [Related]
27. Prenatal and postnatal exposure to PFAS and cardiometabolic factors and inflammation status in children from six European cohorts.
Papadopoulou E; Stratakis N; Basagaña X; Brantsæter AL; Casas M; Fossati S; Gražulevičienė R; Småstuen Haug L; Heude B; Maitre L; McEachan RRC; Robinson O; Roumeliotaki T; Sabidó E; Borràs E; Urquiza J; Vafeiadi M; Zhao Y; Slama R; Wright J; Conti DV; Vrijheid M; Chatzi L
Environ Int; 2021 Dec; 157():106853. PubMed ID: 34500361
[TBL] [Abstract][Full Text] [Related]
28. Exposure to novel and legacy per- and polyfluoroalkyl substances (PFASs) and associations with type 2 diabetes: A case-control study in East China.
Han X; Meng L; Zhang G; Li Y; Shi Y; Zhang Q; Jiang G
Environ Int; 2021 Nov; 156():106637. PubMed ID: 33993001
[TBL] [Abstract][Full Text] [Related]
29. Birth Outcomes in Relation to Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Stress in the Environmental Influences on Child Health Outcomes (ECHO) Program.
Padula AM; Ning X; Bakre S; Barrett ES; Bastain T; Bennett DH; Bloom MS; Breton CV; Dunlop AL; Eick SM; Ferrara A; Fleisch A; Geiger S; Goin DE; Kannan K; Karagas MR; Korrick S; Meeker JD; Morello-Frosch R; O'Connor TG; Oken E; Robinson M; Romano ME; Schantz SL; Schmidt RJ; Starling AP; Zhu Y; Hamra GB; Woodruff TJ;
Environ Health Perspect; 2023 Mar; 131(3):37006. PubMed ID: 36920051
[TBL] [Abstract][Full Text] [Related]
30. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
[TBL] [Abstract][Full Text] [Related]
31. Serum albumin mediates the effect of multiple per- and polyfluoroalkyl substances on serum lipid levels.
Fan Y; Li X; Xu Q; Zhang Y; Yang X; Han X; Du G; Xia Y; Wang X; Lu C
Environ Pollut; 2020 Nov; 266(Pt 2):115138. PubMed ID: 32717635
[TBL] [Abstract][Full Text] [Related]
32. Roles of gender and obesity in defining correlations between perfluoroalkyl substances and lipid/lipoproteins.
Jain RB; Ducatman A
Sci Total Environ; 2019 Feb; 653():74-81. PubMed ID: 30408670
[TBL] [Abstract][Full Text] [Related]
33. Dietary Habits Related to Food Packaging and Population Exposure to PFASs.
Susmann HP; Schaider LA; Rodgers KM; Rudel RA
Environ Health Perspect; 2019 Oct; 127(10):107003. PubMed ID: 31596611
[TBL] [Abstract][Full Text] [Related]
34. Associations between Per- and Polyfluoroalkyl Substances (PFAS) and Cardiometabolic Biomarkers in Adults of Czechia: The Kardiovize Study.
Maranhao Neto GA; Polcrova AB; Pospisilova A; Blaha L; Klanova J; Bobak M; Gonzalez-Rivas JP
Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360776
[TBL] [Abstract][Full Text] [Related]
35. Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study.
Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Fleisch AF; Calafat AM; Webster TF; Horton ES; Oken E
Environ Int; 2019 Aug; 129():343-353. PubMed ID: 31150976
[TBL] [Abstract][Full Text] [Related]
36. Prenatal Exposures to Perfluoroalkyl Acids and Associations with Markers of Adiposity and Plasma Lipids in Infancy: An Odense Child Cohort Study.
Jensen RC; Andersen MS; Larsen PV; Glintborg D; Dalgård C; Timmermann CAG; Nielsen F; Sandberg MB; Andersen HR; Christesen HT; Grandjean P; Jensen TK
Environ Health Perspect; 2020 Jul; 128(7):77001. PubMed ID: 32628516
[TBL] [Abstract][Full Text] [Related]
37. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
[TBL] [Abstract][Full Text] [Related]
38. Prenatal Exposure to Perfluoroalkyl Substances and Cardiometabolic Risk in Children from the Spanish INMA Birth Cohort Study.
Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Romaguera D; Fernández-Barrés S; Santa-Marina L; Basterretxea M; Schettgen T; Valvi D; Vioque J; Sunyer J; Vrijheid M
Environ Health Perspect; 2017 Sep; 125(9):097018. PubMed ID: 28934720
[TBL] [Abstract][Full Text] [Related]
39. Associations of Exposure to Perfluoroalkyl Substances With Thyroid Hormone Concentrations and Birth Size.
Xiao C; Grandjean P; Valvi D; Nielsen F; Jensen TK; Weihe P; Oulhote Y
J Clin Endocrinol Metab; 2020 Mar; 105(3):735-45. PubMed ID: 31665456
[TBL] [Abstract][Full Text] [Related]
40. Estimated exposure to perfluoroalkyl substances during infancy and serum-adipokine concentrations in later childhood.
Grandjean P; Shih YH; Jørgensen LH; Nielsen F; Weihe P; Budtz-Jørgensen E
Pediatr Res; 2023 Nov; 94(5):1832-1837. PubMed ID: 37316707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
